1-(2,3-Dichlorophenyl)piperazine
| Title | Journal |
|---|---|
| Molecular determinants of selectivity and efficacy at the dopamine D3 receptor. | Journal of medicinal chemistry 20120809 |
| A straightforward approach for engineering efficacy and selectivity at GPCRs. | Journal of medicinal chemistry 20120809 |
| Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics. | PloS one 20120101 |
| Synthesis and in vitro antimicrobial study of Schiff base and thiazolidinone of 1-cyclopropyl-6-fluoro-7-[4-(2,3-dichlorophenyl)piperazin-1-yl]-4-quinolone. | Acta poloniae pharmaceutica 20100101 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure. | Journal of medicinal chemistry 20051215 |
| Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. | Bioorganic & medicinal chemistry 20050103 |
| N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. | Bioorganic & medicinal chemistry letters 20030707 |